Stock INIT INITIATOR PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Company Initiator Pharma A/S

Equities

INIT

DK0060775872

Biotechnology & Medical Research

Delayed Nasdaq Stockholm
Other stock markets
 06:24:34 2024-06-03 am EDT 		5-day change 1st Jan Change
10.3 SEK +0.49% Intraday chart for Initiator Pharma A/S +11.96% +11.47%
May. 10 Initiator Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 23 Initiator Pharma A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Business Summary

Initiator Pharma A/S is a Denmark-based company engaged in the biotechnology sector. The Company focuses on developing drugs for treatment of erectile dysfunction.

Number of employees: 3

Managers

Managers TitleAgeSince
Ulf Simonsen FOU
 Founder 61 15-12-31
Claus Elsborg Olesen FOU
 Founder 50 15-12-31
Mikael Søndergaard Thomsen FOU
 Founder 56 15-12-31
Torgeir Vaage DFI
 Director of Finance/CFO 60 15-12-31
Allan Wehnert CTO
 Chief Tech/Sci/R&D Officer - 20-11-30

Members of the board

Members of the board TitleAgeSince
Henrik Kristian Moltke BRD
 Director/Board Member 66 15-12-31
Gunnar Magnus Modee Persson CHM
 Chairman 64 15-12-31
Gunilla Anders Ekström BRD
 Director/Board Member 66 21-12-31
Annette Colin Lövgren BRD
 Director/Board Member 59 21-01-31
Claus Elsborg Olesen FOU
 Founder 50 15-12-31
Peter Holm BRD
 Director/Board Member 50 15-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 56,049,861 43,381,523 ( 77.40 %) 0 77.40 %

Shareholders

NameEquities%Valuation
East Capital Financial Services AB
8.065 %
4,268,081 8.065 % 3 M kr

Company contact information

Initiator Pharma A/S

Ole Maaloesvej 3

2200, Copenhagen

+45 61 26 00 35

http://www.initiatorpharma.com
address Initiator Pharma A/S(INIT)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
INITIATOR PHARMA A/S Stock Initiator Pharma A/S
+11.47% 51.49M
MODERNA, INC. Stock Moderna, Inc.
+43.36% 54.63B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.31% 39.92B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+14.75% 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
-12.56% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.45% 18.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.12% 12.21B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.04% 12.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.04% 11.94B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-11.83% 10.74B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. INIT Stock
  4. Company Initiator Pharma A/S